RANI(Rani Therapeutics Holdings, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $2.72M | $0 | $0 | $1.03M | $1.63M |
| 毛利润 | — | — | — | — | — |
| 营业利润 | −$51.60M | −$63.45M | −$66.10M | −$53.31M | −$38.31M |
| 净利润 | −$8.33M | −$30.59M | −$33.97M | −$30.02M | −$29.67M |
| 经营现金流 | −$32.24M | −$46.52M | −$51.24M | −$35.50M | −$18.71M |
| 自由现金流 | −$32.75M | −$48.13M | −$52.47M | −$35.76M | −$18.80M |
| 摊薄每股收益 | $-0.43 | $-1.28 | $-1.33 | $-1.05 | $-0.45 |